Can you make me a thesis for submandibular gland sparing using imrt
submandibular gland sparing IMRT xerostomia head neck cancer
submandibular gland sparing IMRT head neck cancer clinical outcomes guidelines 2024
submandibular gland sparing IMRT xerostomia quality of life
submandibular gland sparing head neck radiotherapy dosimetric feasibility
IMRT salivary gland sparing xerostomia patient reported outcomes head neck
level IB sparing IMRT oropharyngeal cancer oncologic safety
IMRT parotid submandibular gland dose constraint salivary flow
SMG Sparing IMRT Thesis
Word Document · DOCX
| Chapter | Title | Key Content |
|---|---|---|
| 1 | Introduction | Background, problem statement, aims, significance |
| 2 | Anatomy & Physiology | SMG microanatomy; why SMG loss hits resting saliva hardest (65-70% of resting output) |
| 3 | Radiobiology of Injury | Two-mechanism model (membrane damage + progenitor cell death); dose-response kinetics |
| 4 | IMRT Principles | Technical basis of IMRT; PARSPORT trial; all-gland vs. parotid-only sparing |
| 5 | Patient Selection & Oncologic Safety | Level IB anatomy; HPV+ oropharynx, NPC, OSCC selection criteria; 0 level IB failures at ≤39 Gy |
| 6 | Dose Constraints & Planning | Evidence-based constraint table (SMG ≤39 Gy, parotid ≤26 Gy); contouring; adaptive RT |
| 7 | Clinical Outcomes | Hawkins et al. PROM data; all-gland model superior to parotid-only; swallowing outcomes |
| 8 | SMGT + IMRT | Surgical transfer technique; 75% salivary flow at 12 months; Scrimger et al. Phase II |
| 9 | Discussion | Evidence synthesis; risk stratification; limitations; clinical implications |
| 10 | Conclusions & Future Directions | 7 key conclusions; 6 future research priorities including MR-linac and stem cell sparing |